A paradigm-changing study in the journal Nature by cancer researchers and computer scientists at UC San Diego and other institutions found that short fragments of circular DNA that encode cancer genes are far more common in cancer cells than previously believed.
Six early-career faculty members at the University of California San Diego have won prestigious 2017 Sloan Research Fellowships for achievements that mark them as the nation’s future leaders in science and technology.
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
Engineers at the University of California San Diego have developed a material that could reduce signal losses in photonic devices. The advance has the potential to boost the efficiency of various light-based technologies including fiber optic communication systems, lasers and photovoltaics.
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial scourge that is resistant to most common antibiotics and thus difficult to treat, particularly in children where it commonly causes complicated skin and skin structure infections. In a randomized, controlled clinical trial — the first of its kind — a multi-institution research team reports that daptomycin, part of a new class of antibiotics currently approved only for use in adults, is effective and well-tolerated in children.
A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known as somatic copy-number alterations, may be key to disease progression and might offer new therapeutic approaches for ovarian cancer and other malignancies.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
